Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?The Motley Fool · 15 hr ago
Amgen Inc. (AMGN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress TranscriptSeeking Alpha · 1 day ago
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer StudyMarketBeat · 1 day ago
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?The Motley Fool · 1 day ago
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERGuruFocus · 1 day ago
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancerCNBC · 1 day agoAmgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $5.62 | $6.29 | Beat |
| Apr 30, 2026 | $4.77 | $5.15 | Beat |
| Feb 3, 2026 | $4.73 | $5.29 | Beat |
| Nov 4, 2025 | $5.02 | $5.64 | Beat |
| Aug 5, 2025 | $5.28 | $6.02 | Beat |
| May 1, 2025 | $4.27 | $4.90 | Beat |